ZBTB34 is a hepatocellular carcinoma-associated protein with a monopartite nuclear localization signal.


Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
30 08 2023
Historique:
received: 17 04 2023
accepted: 18 07 2023
medline: 7 9 2023
pubmed: 31 8 2023
entrez: 31 8 2023
Statut: ppublish

Résumé

ZBTB34 is a novel zinc finger protein with an unknown function. In this study, the gene expression and survival prognosis of ZBTB34 were analyzed across tumors based on the TCGA datasets. According to the bioinformatics analysis and qPCR results, liver hepatocellular carcinomas exhibit a high level of ZBTB34 expression. Additionally, the experiment supported the bioinformatics analysis findings that ZBTB34 expression was regulated by miR-125b-5p and that ZBTB34 affected ZBTB10, POLR1B, and AUH expression in HepG2 cells. Biological software analysis further revealed that ZBTB34 contains a monopartite nuclear localization signal (NLS). Arginine and lysine inside the putative NLS were substituted using the alanine-scanning mutagenesis method. The findings showed that the ability of ZBTB34 to enter the nucleus was abolished by the alanine substitution of the sequence

Identifiants

pubmed: 37650557
pii: 204987
doi: 10.18632/aging.204987
pmc: PMC10496988
doi:

Substances chimiques

Nuclear Localization Signals 0
Lysine K3Z4F929H6
Karyopherins 0
Alanine OF5P57N2ZX
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8487-8500

Références

Mol Cell Biol. 2014 Jul;34(13):2382-95
pubmed: 24732804
Int J Genomics. 2022 May 31;2022:5281846
pubmed: 35685832
Cancer Cell Int. 2019 Jul 30;19:203
pubmed: 31384178
Antioxid Redox Signal. 2001 Aug;3(4):535-48
pubmed: 11554443
Nucleic Acids Res. 2019 Feb 28;47(4):1896-1907
pubmed: 30629181
Mol Cancer Ther. 2015 Sep;14(9):2143-53
pubmed: 26162688
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560
pubmed: 31114875
Front Genet. 2020 Oct 26;11:593273
pubmed: 33193737
J Surg Res. 2008 Jan;144(1):158-70
pubmed: 17936790
Cell Death Dis. 2019 Jun 5;10(6):444
pubmed: 31168049
J Cell Physiol. 2022 Feb;237(2):1573-1585
pubmed: 34741317
Oncol Lett. 2018 Oct;16(4):5122-5130
pubmed: 30250580
Aging (Albany NY). 2020 Feb 7;12(3):2921-2938
pubmed: 32035424
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514
pubmed: 32442275
Cell Death Discov. 2017 Nov 13;3:17071
pubmed: 29152378
Int J Genomics. 2022 Nov 29;2022:2723264
pubmed: 36483329
Methods Mol Biol. 2016;1418:111-41
pubmed: 27008012
Genomics. 2020 Nov;112(6):3958-3967
pubmed: 32645525
J Virol. 2019 Apr 17;93(9):
pubmed: 30814281
Transl Oncol. 2020 Dec;13(12):100851
pubmed: 32898766
Biomed Pharmacother. 2017 Nov;95:453-460
pubmed: 28865365
Cold Spring Harb Protoc. 2019 Dec 2;2019(12):
pubmed: 31792145
J Biol Chem. 2007 Feb 23;282(8):5101-5
pubmed: 17170104
Histol Histopathol. 2019 Oct;34(10):1097-1109
pubmed: 31045237
J Biol Chem. 1998 Nov 6;273(45):29764-9
pubmed: 9792690
Gene. 2018 Dec 30;679:179-185
pubmed: 30179682
Aging (Albany NY). 2022 Sep 12;14(17):7126-7136
pubmed: 36098743
J Biochem. 2016 Aug;160(2):69-75
pubmed: 27289017
Mol Cancer Res. 2019 Mar;17(3):794-805
pubmed: 30610105
J Biomed Sci. 2016 Jul 13;23(1):53
pubmed: 27411336
J Biol Chem. 2009 Jan 2;284(1):478-485
pubmed: 19001369
Oncol Rep. 2017 Oct;38(4):2229-2236
pubmed: 28765950
Mol Biol Rep. 2014 Jul;41(7):4513-9
pubmed: 24595450
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Nucleic Acids Res. 2014 Jan;42(1):97-108
pubmed: 24097433
Cell. 2018 Apr 19;173(3):693-705.e22
pubmed: 29677513
BMC Bioinformatics. 2009 Jun 29;10:202
pubmed: 19563654
Biochem J. 2015 Feb 15;466(1):13-28
pubmed: 25656054
Mol Cell Biochem. 2006 Oct;290(1-2):159-67
pubmed: 16718364
Cell Commun Signal. 2021 May 22;19(1):60
pubmed: 34022911
Asian Pac J Cancer Prev. 2022 Apr 01;23(4):1137-1145
pubmed: 35485668
PeerJ. 2020 Jun 11;8:e9328
pubmed: 32566409
Proc Jpn Acad Ser B Phys Biol Sci. 2018;94(7):259-274
pubmed: 30078827
J Mol Biol. 2016 May 22;428(10 Pt A):2060-90
pubmed: 26523678
Cancer Res. 2020 Jun 15;80(12):2599-2611
pubmed: 32312832
Cell. 2003 Dec 26;115(7):787-98
pubmed: 14697198
Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188731
pubmed: 35483489
Oncol Lett. 2020 Jan;19(1):671-680
pubmed: 31897183
Nat Rev Mol Cell Biol. 2017 Apr;18(4):229-245
pubmed: 28120913

Auteurs

Zheng Liu (Z)

College of Medical Laboratory Science, Guilin Medical University, Guilin 541004, Guangxi, China.
Guihang Guiyang Hospital Affiliated to Zunyi Medical University, Guiyang 550027, Guizhou, China.

Di Jin (D)

College of Medical Laboratory Science, Guilin Medical University, Guilin 541004, Guangxi, China.

Xinran Wei (X)

College of Medical Laboratory Science, Guilin Medical University, Guilin 541004, Guangxi, China.

Yue Gao (Y)

College of Medical Laboratory Science, Guilin Medical University, Guilin 541004, Guangxi, China.

Xiaodie Gao (X)

College of Medical Laboratory Science, Guilin Medical University, Guilin 541004, Guangxi, China.

Xia Li (X)

Clinical Laboratory, Hospital Affiliated to Guilin Medical University, Guilin 541001, Guangxi, China.

Xiujuan Wang (X)

College of Medical Laboratory Science, Guilin Medical University, Guilin 541004, Guangxi, China.

Pingying Wei (P)

College of Medical Laboratory Science, Guilin Medical University, Guilin 541004, Guangxi, China.

Tao Liu (T)

Guihang Guiyang Hospital Affiliated to Zunyi Medical University, Guiyang 550027, Guizhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH